The Cost of Trump’s Drug Tariff Policy
Americans are paying more for medications than any other country in the world. While most nations use similar drugs, the United States consistently holds the highest prices. This situation has been exacerbated by recent policy decisions that have placed an even greater burden on patients and healthcare systems.
Donald Trump’s administration has taken a controversial approach to drug pricing by imposing a 15% tariff on branded European pharmaceuticals. This move is not only alarming but also unconstitutional, as it violates the clear division of powers outlined in the U.S. Constitution, which reserves the authority to impose tariffs solely with Congress. Trump claims emergency powers to bypass this constitutional requirement, but there is no actual emergency. Instead, he is breaking the law without accountability.
The impact of these tariffs is already being felt across the healthcare system. Europe supplies approximately 60% of all U.S. pharmaceutical imports by value, totaling around $127 billion annually. These imports include essential medicines such as:
- Ozempic and Wegovy for diabetes and weight loss, manufactured in Denmark and Belgium
- Humira and Stelara for Crohn’s disease, arthritis, and psoriasis, produced in Ireland
- Keytruda, a groundbreaking cancer treatment used daily in hospitals
- Botox and Viagra, popular among various demographics
These drugs are integral to the health of millions of Americans. However, the new tariffs will likely result in higher costs for patients, increased insurance premiums, and a greater financial burden on Medicare and Medicaid. Analysts estimate that this tariff scheme could add between $13 to $19 billion annually to the U.S. healthcare system, further straining an already overburdened system.
Trump has long claimed to support lowering drug prices, yet his policies are doing the opposite. The consequences of rising drug prices can be deadly. Patients may cut doses, skip refills, or avoid purchasing medications altogether. For those with chronic conditions like diabetes or cancer, this can lead to severe health complications or even death.
This pattern of policy as punishment is evident in Trump’s second term. He has attacked reproductive rights, weakened environmental protections, and now is using medicine as a bargaining chip. His actions are happening at a rapid pace, with little resistance from Congress or the courts.
Even the pharmaceutical industry, known for its high drug prices, warned against this move. They told the Commerce Department that the tariffs would backfire, increase costs, and harm patients. Trump ignored these warnings, prioritizing his ego and political image over the well-being of American citizens.
This issue also highlights a broader problem: the lack of guaranteed healthcare for all Americans. In countries with universal healthcare systems, governments negotiate drug prices and protect patients. Without such a system, the U.S. remains vulnerable to policies that prioritize profit over people.
Trump’s “America First” rhetoric masks a reality where ordinary Americans pay more at the pharmacy, face higher premiums and taxes, and experience fewer options and longer waits for new therapies. Meanwhile, Trump benefits from the public perception of being “tough on Europe.”
This tariff plan, justified by a non-existent emergency, is just one example of how Trump’s policies are undermining the foundations of the U.S. Constitution and threatening the health of its citizens. If left unchecked, more of the same can be expected: higher costs, less coverage, and preventable deaths due to unaffordable medication.
Trump calls this “America First,” but it is more accurately described as “America last,” with Trump and his allies benefiting first. The most expensive prescriptions in the world continue to be sold in the U.S., while other countries pay significantly less. It is crucial for Americans to recognize the true cost of these policies and take action to protect their health and future.
Leave a Reply